# Methazolamide-induced toxic epidermal necrolysis in a Chinese woman with HLA-B5901

## Metadata
**Authors:** Yonghao Xu, Mengqi Wu, Fang Sheng, Qing Sun
**Journal:** Indian Journal of Ophthalmology
**Date:** 2015 Jul
**DOI:** [10.4103/0301-4738.167105](https://doi.org/10.4103/0301-4738.167105)
**PMID:** 26458485
**PMCID:** PMC4652259
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652259/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC4652259/pdf/IJO-63-623b.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC4652259/pdf/IJO-63-623b.pdf)

### Financial support and sponsorship

Nil.

### Conflicts of interest

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

## References

1. Tanaka M. Methazolamide induced toxic epidermal necrolysis. Rhisho Derma. 1989;43:327–30.  [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Rhisho%20Derma&title=Methazolamide%20induced%20toxic%20epidermal%20necrolysis&author=M%20Tanaka&volume=43&publication_year=1989&pages=327-30&)

2. Flach AJ, Smith RE, Fraunfelder FT. Stevens-Johnson syndrome associated with methazolamide treatment reported in two Japanese-American women. Ophthalmology. 1995;102:1677–80. doi: 10.1016/s0161-6420(95)30810-x.  [DOI](https://doi.org/10.1016/s0161-6420(95)30810-x) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/9098261/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ophthalmology&title=Stevens-Johnson%20syndrome%20associated%20with%20methazolamide%20treatment%20reported%20in%20two%20Japanese-American%20women&author=AJ%20Flach&author=RE%20Smith&author=FT%20Fraunfelder&volume=102&publication_year=1995&pages=1677-80&pmid=9098261&doi=10.1016/s0161-6420(95)30810-x&)

3. Shirato S, Kagaya F, Suzuki Y, Joukou S. Stevens-Johnson syndrome induced by methazolamide treatment. Arch Ophthalmol. 1997;115:550–3. doi: 10.1001/archopht.1997.01100150552021.  [DOI](https://doi.org/10.1001/archopht.1997.01100150552021) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/9109770/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Arch%20Ophthalmol&title=Stevens-Johnson%20syndrome%20induced%20by%20methazolamide%20treatment&author=S%20Shirato&author=F%20Kagaya&author=Y%20Suzuki&author=S%20Joukou&volume=115&publication_year=1997&pages=550-3&pmid=9109770&doi=10.1001/archopht.1997.01100150552021&)

4. Kim SH, Kim M, Lee KW, Kim SH, Kang HR, Park HW, et al. HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Pharmacogenomics. 2010;11:879–84. doi: 10.2217/pgs.10.54.  [DOI](https://doi.org/10.2217/pgs.10.54) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/20504258/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics&title=HLA-B*5901%20is%20strongly%20associated%20with%20methazolamide-induced%20Stevens-Johnson%20syndrome/toxic%20epidermal%20necrolysis&author=SH%20Kim&author=M%20Kim&author=KW%20Lee&author=SH%20Kim&author=HR%20Kang&volume=11&publication_year=2010&pages=879-84&pmid=20504258&doi=10.2217/pgs.10.54&)
